These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16013989)

  • 1. Lamotrigine in the treatment of bipolar disorder.
    Bhagwagar Z; Goodwin GM
    Expert Opin Pharmacother; 2005 Jul; 6(8):1401-8. PubMed ID: 16013989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotlight on lamotrigine in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine: a review of its use in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
    Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
    J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine update and its use in mood disorders.
    Hurley SC
    Ann Pharmacother; 2002 May; 36(5):860-73. PubMed ID: 11978166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications.
    Seo HJ; Chiesa A; Lee SJ; Patkar AA; Han C; Masand PS; Serretti A; Pae CU
    Clin Neuropharmacol; 2011; 34(1):39-47. PubMed ID: 21242744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine in the treatment of bipolar disorder.
    Bowden CL
    Expert Opin Pharmacother; 2002 Oct; 3(10):1513-9. PubMed ID: 12387697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.
    Calabrese JR; Bowden CL; McElroy SL; Cookson J; Andersen J; Keck PE; Rhodes L; Bolden-Watson C; Zhou J; Ascher JA
    Am J Psychiatry; 1999 Jul; 156(7):1019-23. PubMed ID: 10401445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lamotrigine for adults with bipolar disorder in a private practice setting.
    Ginsberg LD
    CNS Spectr; 2006 May; 11(5):376-82. PubMed ID: 16641842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine for the treatment of bipolar disorder.
    Engle PM; Heck AM
    Ann Pharmacother; 2000 Feb; 34(2):258-62. PubMed ID: 10676836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine-associated rash: to rechallenge or not to rechallenge?
    Lorberg B; Youssef NA; Bhagwagar Z
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):257-65. PubMed ID: 18845017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of lamotrigine for bipolar disorder.
    Bowden CL; Asnis GM; Ginsberg LD; Bentley B; Leadbetter R; White R
    Drug Saf; 2004; 27(3):173-84. PubMed ID: 14756579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.
    Sporn J; Sachs G
    J Clin Psychopharmacol; 1997 Jun; 17(3):185-9. PubMed ID: 9169963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine for bipolar disorder: translating research into clinical practice.
    Fung J; Mok H; Yatham LN
    Expert Rev Neurother; 2004 May; 4(3):363-70. PubMed ID: 15853534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Muzina DJ; Elhaj O; Gajwani P; Gao K; Calabrese JR
    Acta Psychiatr Scand Suppl; 2005; (426):21-8. PubMed ID: 15833097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current understanding of lamotrigine as a mood stabilizer.
    Hahn CG; Gyulai L; Baldassano CF; Lenox RH
    J Clin Psychiatry; 2004 Jun; 65(6):791-804. PubMed ID: 15291656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.